Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1988 1
2001 1
2002 3
2004 4
2005 7
2006 7
2007 8
2008 6
2009 3
2010 3
2011 10
2012 8
2013 10
2014 5
2015 13
2016 13
2017 10
2018 13
2019 19
2020 15
2021 11
2022 13
2023 14
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

183 results

Results by year

Filters applied: . Clear all
Page 1
Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium.
Hansen DK, Sidana S, Peres LC, Colin Leitzinger C, Shune L, Shrewsbury A, Gonzalez R, Sborov DW, Wagner C, Dima D, Hashmi H, Kocoglu MH, Atrash S, Simmons G, Kalariya N, Ferreri C, Afrough A, Kansagra A, Voorhees P, Baz R, Khouri J, Alsina M, McGuirk J, Locke FL, Patel KK. Hansen DK, et al. Among authors: ferreri c. J Clin Oncol. 2023 Apr 10;41(11):2087-2097. doi: 10.1200/JCO.22.01365. Epub 2023 Jan 9. J Clin Oncol. 2023. PMID: 36623248
Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease.
Svegliati-Baroni G, Pierantonelli I, Torquato P, Marinelli R, Ferreri C, Chatgilialoglu C, Bartolini D, Galli F. Svegliati-Baroni G, et al. Among authors: ferreri c. Free Radic Biol Med. 2019 Nov 20;144:293-309. doi: 10.1016/j.freeradbiomed.2019.05.029. Epub 2019 May 29. Free Radic Biol Med. 2019. PMID: 31152791 Review.
Antibody Drug Conjugates in Multiple Myeloma.
Ferreri CJ, Lee HC. Ferreri CJ, et al. Cancer J. 2022 Nov-Dec 01;28(6):488-495. doi: 10.1097/PPO.0000000000000628. Cancer J. 2022. PMID: 36383912 Review.
Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy.
Ferreri CJ, Hildebrandt MAT, Hashmi H, Shune LO, McGuirk JP, Sborov DW, Wagner CB, Kocoglu MH, Rapoport A, Atrash S, Voorhees PM, Khouri J, Dima D, Afrough A, Kaur G, Anderson LD Jr, Simmons G, Davis JA, Kalariya N, Peres LC, Lin Y, Janakiram M, Nadeem O, Alsina M, Locke FL, Sidana S, Hansen DK, Patel KK, Castaneda Puglianini OA. Ferreri CJ, et al. Blood Cancer J. 2023 Aug 9;13(1):117. doi: 10.1038/s41408-023-00886-8. Blood Cancer J. 2023. PMID: 37558706 Free PMC article.
Purine 5',8-cyclonucleoside lesions: chemistry and biology.
Chatgilialoglu C, Ferreri C, Terzidis MA. Chatgilialoglu C, et al. Among authors: ferreri c. Chem Soc Rev. 2011 Mar;40(3):1368-82. doi: 10.1039/c0cs00061b. Epub 2011 Jan 11. Chem Soc Rev. 2011. PMID: 21221459 Review.
Targeted and untargeted metabolomic approach for GDM diagnosis.
Burzynska-Pedziwiatr I, Dudzik D, Sansone A, Malachowska B, Zieleniak A, Zurawska-Klis M, Ferreri C, Chatgilialoglu C, Cypryk K, Wozniak LA, Markuszewski MJ, Bukowiecka-Matusiak M. Burzynska-Pedziwiatr I, et al. Among authors: ferreri c. Front Mol Biosci. 2023 Jan 5;9:997436. doi: 10.3389/fmolb.2022.997436. eCollection 2022. Front Mol Biosci. 2023. PMID: 36685282 Free PMC article.
Trans lipids: the free radical path.
Chatgilialoglu C, Ferreri C. Chatgilialoglu C, et al. Among authors: ferreri c. Acc Chem Res. 2005 Jun;38(6):441-8. doi: 10.1021/ar0400847. Acc Chem Res. 2005. PMID: 15966710 Review.
Biomimetic models of radical stress and related biomarkers.
Chatgilialoglu C, Ferreri C, Masi A, Melchiorre M, Sansone A, Terzidis MA, Torreggiani A. Chatgilialoglu C, et al. Among authors: ferreri c. Chimia (Aarau). 2012;66(6):368-71. doi: 10.2533/chimia.2012.368. Chimia (Aarau). 2012. PMID: 22871276 Free article. Review.
183 results